PSCM
BNR

Prince Street Capital Management’s Burning Rock Biotech BNR Stock Holding History

Prince Street Capital Management’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,400
Closed -$3.29M – 16
2021
Q3 		$3.29M Buy
18,400
+1,900
+12% +$422K 2.05% 12
2021
Q2 		$4.86M Buy
+16,500
New +$4.88M 2.9% 12

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Prince Street Capital Management's BNR Position: Q4 2021 in Review

Prince Street Capital Management sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 18,400 shares — an estimated $3.29M sold.

Prince Street Capital Management first reported a position in BNR in Q2 2021 and held it in 2 quarters. The position peaked at $4.86M in Q2 2021. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

  • Prince Street Capital Management reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
  • Prince Street Capital Management sold 18,400 Burning Rock Biotech shares in Q4 2021, an estimated $3.29M.
  • Prince Street Capital Management first reported a position in Burning Rock Biotech in Q2 2021 and held it in 2 quarters.
  • Prince Street Capital Management's Burning Rock Biotech position peaked at $4.86M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on Prince Street Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.